FDG-PET/CT Accurate in Diagnosing Breast Cancer Recurrence

March 28, 2016

[18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point imaging was accurate in diagnosing breast cancer recurrence with only a small number of false-positive cases, a study published in the Journal of Clinical Oncology has shown.1

For the study, researchers sought to investigate diagnostic accuracy of FDG-PET/CT, contrast-enhanced CT, and bone scintigraphy in patients with suspected breast cancer recurrence.

Read the full article.